T. Smutny, M. Bitman, M. Urban, M. Dubecka, R. Vrzal, Z. Dvorak, P. Pavek: U0126, a mitogen-activated protein kinase kinase 1 and 2 (MEK1 and 2) inhibitor, selectively up-regulates main isoforms of CYP3A subfamily via a pregnane X receptor (PXR) in HepG2 cells. In: Archives of Toxicology. Band 88, Nummer 12, Dezember 2014, S. 2243–2259, doi:10.1007/s00204-014-1254-2. PMID 24819614.
V. Doyère, J. Debiec, M. H. Monfils, G. E. Schafe, J. E. LeDoux: Synapse-specific reconsolidation of distinct fear memories in the lateral amygdala. In: Nature Neuroscience. Band 10, Nummer 4, April 2007, S. 414–416, doi:10.1038/nn1871. PMID 17351634.
Q. Ong, S. Guo, K. Zhang, B. Cui: U0126 Protects Cells against Oxidative Stress Independent of Its Function as a MEK Inhibitor. In: ACS Chemical Neuroscience. [elektronische Veröffentlichung vor dem Druck] Januar 2015, doi:10.1021/cn500288n. PMID 25544156.
C. Evans, S. J. Cook, M. P. Coleman, J. Gilley: MEK inhibitor U0126 reverses protection of axons from Wallerian degeneration independently of MEK-ERK signaling. In: PLOS ONE. Band 8, Nummer 10, 2013, S. e76505, doi:10.1371/journal.pone.0076505. PMID 24124570. PMC 3790678 (freier Volltext).
M. F. Favata, K. Y. Horiuchi, E. J. Manos, A. J. Daulerio, D. A. Stradley, W. S. Feeser, D. E. Van Dyk, W. J. Pitts, R. A. Earl, F. Hobbs, R. A. Copeland, R. L. Magolda, P. A. Scherle, J. M. Trzaskos: Identification of a novel inhibitor of mitogen-activated protein kinase kinase. In: The Journal of Biological Chemistry. Band 273, Nummer 29, Juli 1998, S. 18623–18632, PMID 9660836.
J. V. Duncia, J. B. Santella, C. A. Higley, W. J. Pitts, J. Wityak, W. E. Frietze, F. W. Rankin, J. H. Sun, R. A. Earl, A. C. Tabaka, C. A. Teleha, K. F. Blom, M. F. Favata, E. J. Manos, A. J. Daulerio, D. A. Stradley, K. Horiuchi, R. A. Copeland, P. A. Scherle, J. M. Trzaskos, R. L. Magolda, G. L. Trainor, R. R. Wexler, F. W. Hobbs, R. E. Olson: MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products. In: Bioorganic & Medicinal Chemistry Letters. Band 8, Nummer 20, Oktober 1998, S. 2839–2844, PMID 9873633.
H. Fukazawa, K. Noguchi, Y. Murakami, Y. Uehara: Mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway. In: Molecular Cancer Therapeutics. Band 1, Nummer 5, März 2002, S. 303–309, PMID 12489846.
P. Bachleda, Z. Dvorák: Pharmacological inhibitors of JNK and ERK kinases SP600125 and U0126 are not appropriate tools for studies of drug metabolism because they activate aryl hydrocarbon receptor. In: General Physiology and Biophysics. Band 27, Nummer 2, Juni 2008, S. 143–145, PMID 18645229.
T. Smutny, M. Bitman, M. Urban, M. Dubecka, R. Vrzal, Z. Dvorak, P. Pavek: U0126, a mitogen-activated protein kinase kinase 1 and 2 (MEK1 and 2) inhibitor, selectively up-regulates main isoforms of CYP3A subfamily via a pregnane X receptor (PXR) in HepG2 cells. In: Archives of Toxicology. Band 88, Nummer 12, Dezember 2014, S. 2243–2259, doi:10.1007/s00204-014-1254-2. PMID 24819614.
V. Doyère, J. Debiec, M. H. Monfils, G. E. Schafe, J. E. LeDoux: Synapse-specific reconsolidation of distinct fear memories in the lateral amygdala. In: Nature Neuroscience. Band 10, Nummer 4, April 2007, S. 414–416, doi:10.1038/nn1871. PMID 17351634.
Q. Ong, S. Guo, K. Zhang, B. Cui: U0126 Protects Cells against Oxidative Stress Independent of Its Function as a MEK Inhibitor. In: ACS Chemical Neuroscience. [elektronische Veröffentlichung vor dem Druck] Januar 2015, doi:10.1021/cn500288n. PMID 25544156.
C. Evans, S. J. Cook, M. P. Coleman, J. Gilley: MEK inhibitor U0126 reverses protection of axons from Wallerian degeneration independently of MEK-ERK signaling. In: PLOS ONE. Band 8, Nummer 10, 2013, S. e76505, doi:10.1371/journal.pone.0076505. PMID 24124570. PMC 3790678 (freier Volltext).
